Showing 2725 results for "amyotrophic lateral sclerosis (ALS)"

Talking to Children about ALS

Explaining amyotrophic lateral sclerosis (ALS) to children can be a daunting task. ALS Worldwide has some notes that can help. You can read more here: https://bit.ly/1SE5H49 Keep updated about ALS here: https://bit.ly/1QHMBGw…

Antiretroviral Therapy for Sporadic ALS?

Some forms of amyotrophic lateral sclerosis (ALS) could actually be caused by an infectious virus, with scientists reporting that human endogenous retrovirus-K (HERV-K), normally dormant, has been found in an active form in the postmortem brain cells of certain individuals with ALS. Experiments using the active HERV-K…

Baylor and UCB Partner to Develop Therapies for ALS, Other Neurodegenerative Ills

Baylor College of Medicine and the Belgium-based biopharmaceutical company UCB announced that they have entered into a strategic partnership, led by Baylor Professor Huda Zoghbi, to discover new medicines to better treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). The research alliance is in keeping UCB’s commitment to accelerating the discovery…

Sensory Neurons in ALS

In a study published in the Journal of Comparative Neurology, researchers found the same sensory neurons that keep a person from dropping a glass of water are implicated in amyotrophic lateral sclerosis (ALS), and because these neurons are easier to study in the laboratory than motor neurons, they may help advance new therapies for the…

Last Week’s Hot Topic on ALS

Last week’s hot topic on ALS was ALS, Gulf War Illness Caused by Toxic Exposures, Report Says written by Magdalena Kegel.  The article refers to a report which shows that Gulf War Illness is a result of exposure to pesticides and other toxins used in the Gulf War.

ProMIS Forms Key Advisory Boards to Advance Its ALS, Alzheimer’s Therapies

ProMIS Neurosciences announced that it has established Business (BAB) and Scientific (SAB) advisory boards to advance the company’s work. ProMIS is developing its first products focused on more effective treatments of amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD). “Our number one goal is to create the appropriate precision therapeutics and companion diagnostics…

ALS Patients to be Able to Communicate with Their Families in Their Own Voice

The Augmentative Communication Program (ACP) at Boston Children’s Hospital has received a $1.5 million donation to set up a program focused on improving the quality of life of amyotrophic lateral sclerosis (ALS) adult patients. “If you could not speak and you want to say to someone, ‘I’m thirsty,’ a computer-generated synthetic voice is fine.